Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.16

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.16. Revenue for the quarter came in at $10.9 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Morgan Stanley Downgrades Peloton Interactive (PTON) to Underweight
• UBS Upgrades Feng Tay Enterprises (9910:TT) to Buy